Contributed By Walder Wyss Ltd
Advertising directed at the general public pursuant to Article 15 lit. a (advertisements in newspapers, magazines and books, brochures, posters, newsletters, etc) and lit. c AWV (advertising using electronic media such as image, sound and data carriers as well as application software) for analgesics, sleeping aids, sedatives, laxatives and anorexics must be submitted to Swissmedic for approval prior to publication if the drug information mentions a potential for abuse or dependence. Swissmedic may require a marketing authorisation holder who seriously or repeatedly infringes the provisions governing the advertising of medicines to submit to Swissmedic, for a reasonable period of time, all drafts of the planned advertising in the form specified by Swissmedic for review and approval prior to its appearance (Article 23 AWV).